Parham Ramezani-Rad

955 total citations
19 papers, 615 citations indexed

About

Parham Ramezani-Rad is a scholar working on Immunology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Parham Ramezani-Rad has authored 19 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Hematology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Parham Ramezani-Rad's work include Acute Lymphoblastic Leukemia research (7 papers), T-cell and B-cell Immunology (7 papers) and Immune Cell Function and Interaction (7 papers). Parham Ramezani-Rad is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), T-cell and B-cell Immunology (7 papers) and Immune Cell Function and Interaction (7 papers). Parham Ramezani-Rad collaborates with scholars based in United States, Germany and Canada. Parham Ramezani-Rad's co-authors include Robert C. Rickert, Cindi Chen, John Apgar, Matthew H. Cato, Julia Jellusova, James R. Woodgett, Adam Richardson, Elaine M. Conner, Robert J. Benschop and John R. Šedý and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and Nature Immunology.

In The Last Decade

Parham Ramezani-Rad

19 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Parham Ramezani-Rad United States 9 263 262 124 105 97 19 615
Cristina Mirantes Spain 13 142 0.5× 279 1.1× 93 0.8× 168 1.6× 45 0.5× 17 595
Koichi R. Katsumura United States 18 170 0.6× 578 2.2× 257 2.1× 107 1.0× 105 1.1× 24 863
Jun Mo United States 10 125 0.5× 235 0.9× 168 1.4× 80 0.8× 49 0.5× 26 480
Cyril Šálek Czechia 14 311 1.2× 243 0.9× 201 1.6× 275 2.6× 85 0.9× 47 728
Sarah Ogilvy Australia 9 410 1.6× 510 1.9× 219 1.8× 169 1.6× 96 1.0× 11 910
Maxim Kebenko Germany 12 165 0.6× 243 0.9× 135 1.1× 265 2.5× 62 0.6× 30 609
Quangeng Zhang China 9 229 0.9× 352 1.3× 98 0.8× 134 1.3× 99 1.0× 12 747
Piotr Grabarczyk Germany 16 224 0.9× 336 1.3× 98 0.8× 191 1.8× 62 0.6× 36 663
Tatsuo Abe Japan 14 152 0.6× 339 1.3× 125 1.0× 119 1.1× 72 0.7× 26 660
Deborah Clarke United Kingdom 13 275 1.0× 441 1.7× 162 1.3× 124 1.2× 39 0.4× 20 719

Countries citing papers authored by Parham Ramezani-Rad

Since Specialization
Citations

This map shows the geographic impact of Parham Ramezani-Rad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parham Ramezani-Rad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parham Ramezani-Rad more than expected).

Fields of papers citing papers by Parham Ramezani-Rad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parham Ramezani-Rad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parham Ramezani-Rad. The network helps show where Parham Ramezani-Rad may publish in the future.

Co-authorship network of co-authors of Parham Ramezani-Rad

This figure shows the co-authorship network connecting the top 25 collaborators of Parham Ramezani-Rad. A scholar is included among the top collaborators of Parham Ramezani-Rad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parham Ramezani-Rad. Parham Ramezani-Rad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bhat, Numana, Richard Virgen‐Slane, Parham Ramezani-Rad, et al.. (2021). Regnase-1 is essential for B cell homeostasis to prevent immunopathology. The Journal of Experimental Medicine. 218(5). 17 indexed citations
2.
Ramezani-Rad, Parham & Robert C. Rickert. (2021). Quick and easy purification of murine untouched naive B cells or germinal center B cells by MACS. STAR Protocols. 2(1). 100369–100369. 4 indexed citations
3.
Virgen‐Slane, Richard, Ricardo G. Correa, Parham Ramezani-Rad, et al.. (2020). Cutting Edge: The RNA-Binding Protein Ewing Sarcoma Is a Novel Modulator of Lymphotoxin β Receptor Signaling. The Journal of Immunology. 204(5). 1085–1090. 1 indexed citations
4.
Ramezani-Rad, Parham, et al.. (2020). Cyclin D3 Governs Clonal Expansion of Dark Zone Germinal Center B Cells. Cell Reports. 33(7). 108403–108403. 28 indexed citations
5.
Ramezani-Rad, Parham, et al.. (2020). E3 Ubiquitin Ligase Fbw7 Regulates the Survival of Mature B Cells. The Journal of Immunology. 204(6). 1535–1542. 7 indexed citations
6.
Šedý, John R. & Parham Ramezani-Rad. (2019). HVEM network signaling in cancer. Advances in cancer research. 142. 145–186. 39 indexed citations
7.
Ramezani-Rad, Parham, et al.. (2019). The AKT isoforms 1 and 2 drive B cell fate decisions during the germinal center response. Life Science Alliance. 2(6). e201900506–e201900506. 20 indexed citations
8.
Deshpande, Anagha, Benson Chen, Parham Ramezani-Rad, et al.. (2018). Targeting MYC-Driven B-Cell Lymphoma By Inhibition of the Histone Methyltransferase DOT1L. Blood. 132(Supplement 1). 2839–2839. 1 indexed citations
9.
Jellusova, Julia, Matthew H. Cato, John Apgar, et al.. (2017). Gsk3 is a metabolic checkpoint regulator in B cells. Nature Immunology. 18(3). 303–312. 227 indexed citations
10.
Ramezani-Rad, Parham & Robert C. Rickert. (2017). Murine models of germinal center derived-lymphomas. Current Opinion in Immunology. 45. 31–36. 12 indexed citations
11.
Ramezani-Rad, Parham, Huimin Geng, Christian Hurtz, et al.. (2012). SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia. Blood. 121(1). 148–155. 64 indexed citations
12.
Masouleh, Behzad Kharabi, Christian Hurtz, Huimin Geng, et al.. (2012). Targeting the UPR-Transcription Factor XBP1 to Overcome Drug-Resistance in Ph+ ALL. Blood. 120(21). 872–872. 1 indexed citations
13.
Ramezani-Rad, Parham, Huimin Geng, Lai N. Chan, et al.. (2012). SOX4 enables Oncogenic Survival Signals in Acute Lymphoblastic Leukemia. Blood. 120(21). 863–863. 3 indexed citations
14.
Nahar, Rahul, Parham Ramezani-Rad, Maximilian Mossner, et al.. (2011). Pre-B Cell Receptor-Mediated Activation of BCL6 Induces Pre-B Cell Quiescence Through Transcriptional Repression of MYC. Blood. 118(21). 1406–1406. 1 indexed citations
15.
Nahar, Rahul, Parham Ramezani-Rad, Maximilian Mossner, et al.. (2011). Pre-B cell receptor–mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC. Blood. 118(15). 4174–4178. 48 indexed citations
16.
Nahar, Rahul, Parham Ramezani-Rad, Sinisa Dovat, et al.. (2011). Mechanisms of Ikaros-Mediated Tumor Suppression. Blood. 118(21). 408–408. 1 indexed citations
17.
Hurtz, Christian, Katerina Hatzi, Leandro Cerchietti, et al.. (2011). BCL6-Mediated Repression of p53 Is Critical for Leukemia Stem Cell Survival in Chronic Myeloid Leukemia. Blood. 118(21). 446–446. 2 indexed citations
18.
Hurtz, Christian, Katerina Hatzi, Leandro Cerchietti, et al.. (2011). BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia. The Journal of Experimental Medicine. 208(11). 2163–2174. 138 indexed citations
19.
Nahar, Rahul, Parham Ramezani-Rad, Cihangir Duy, et al.. (2010). IKAROS and BCL6 Limit Pre-B Cell Expansion and Prevent Leukemogenesis Downstream of the Pre-B Cell Receptor. Blood. 116(21). 146–146. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026